Oxazoles
Aobchem 2-(2-Bromo-4 5-difluorophenoxy)propane | ≥97% | CAS 1266253-67-1 | C9H9BrF2O | 1g
2-(2-Bromo-4 5-difluorophenoxy)propane | ≥97% | CAS 1266253-67-1 | C9H9BrF2O | 1g
Aobchem 1-((3-Methoxyphenyl)sulfonyl)piperidine | 95% | CAS 173681-65-7 | C12H17NO3S | 5g
1-((3-Methoxyphenyl)sulfonyl)piperidine | 95% | CAS 173681-65-7 | C12H17NO3S | 5g
Aobchem Trimethyl(5-pentylthiophen-2-yl)silane | 95% | C12H22SSi | 500mg
Trimethyl(5-pentylthiophen-2-yl)silane | 95% | C12H22SSi | 500mg
Aobchem (2 6-Dichloro-4-methoxyphenyl)(phenyl)methanol | 95% | C14H12Cl2O2 | 1g
(2 6-Dichloro-4-methoxyphenyl)(phenyl)methanol | 95% | C14H12Cl2O2 | 1g
Aobchem (3-Cyclopentyl-5-methoxyphenyl)boronic acid | 95% | C12H17BO3 | 500mg
(3-Cyclopentyl-5-methoxyphenyl)boronic acid | 95% | C12H17BO3 | 500mg
Medchemexpress LLC Y-27632 dihydrochloride | 129830-38-2 | MFCD03490488 | 99.9% | 320.26 | C14H23Cl2N3O | 100 MG
Y-27632 dihydrochloride is an ATP-competitive inhibitor of Rho-associated kinases (ROCK) used as a research reagent in cell biology and pharmacology studies. It is orally active and has documented kinase selectivity and potency.
- ATP-competitive inhibitor of ROCK-I and ROCK-II.
- Orally active compound with reported antiepileptic effects.
- Reported Ki values: ROCK-I 220 nM, ROCK-II 300 nM.
- High reported purity (≈99.94%).
- Available in multiple solid pack sizes and bulk by inquiry.
Aobchem 2-Formyl-4-methoxyphenyl acetate | 97% | CAS 62536-85-0 | C10H10O4 | 250mg
2-Formyl-4-methoxyphenyl acetate | 97% | CAS 62536-85-0 | C10H10O4 | 250mg
Aobchem 1-(2-Ethoxy-5-methoxyphenyl)cyclobutanol | 95% | C13H18O3 | 250mg
1-(2-Ethoxy-5-methoxyphenyl)cyclobutanol | 95% | C13H18O3 | 250mg
Aobchem 1-(2-Ethoxy-5-methoxyphenyl)ethanol | 95% | C11H16O3 | 1g
1-(2-Ethoxy-5-methoxyphenyl)ethanol | 95% | C11H16O3 | 1g